Researchers continue to excited about the medication , a novel dual agonist showing remarkable results in early trials for weight loss . It functions by modulating several pathways : GLP-1 and GIP, these, when engaged , support influence appetite and enhance metabolism . Preliminary reports indicate substantial size loss and likely improvements for